James Quigley
Stock Analyst at Goldman Sachs
(0.35)
# 4,544
Out of 5,119 analysts
301
Total ratings
41.8%
Success rate
-5.2%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €63.50 → €66.00 | €55.58 | +18.75% | 62 | Nov 4, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Sell | CHF 110.00 → CHF 113.00 | CHF 133.08 | -15.09% | 30 | Oct 28, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 366.00 → CHF 391.00 | CHF 390.30 | +0.18% | 28 | Oct 23, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Hold | €244.00 → €258.00 | €290.00 | -11.03% | 33 | Oct 23, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €223.00 → €235.00 | €225.80 | +4.07% | 25 | Oct 23, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 680.00 | CHF 663.40 | +2.50% | 23 | Oct 1, 2026 | |
| NVO Novo Nordisk | Reiterated: Hold | $47 → $44 | $40.31 | +9.15% | 10 | Aug 6, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €89.00 → €84.00 | €83.74 | +0.31% | 10 | Jul 6, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Buy | €153.00 → €147.00 | €148.75 | -1.18% | 43 | Apr 16, 2026 | |
| RHHBY Roche Holding AG | Upgraded: Hold | n/a | $59.37 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $162.55 | n/a | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $950.00 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $60 | $47.04 | n/a | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | 13,930p | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €13.00 → €10.50 | €0.80 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | CHF 65.00 → CHF 64.00 | CHF 79.70 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 38.00 → CHF 21.00 | CHF 40.05 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €27.00 → €28.00 | €3.16 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €38.00 → €36.00 | €29.62 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $15 | $1.69 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $33.45 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $53.63 | n/a | 1 | Jun 20, 2018 |
Bayer Aktiengesellschaft
Nov 4, 2026
Reiterated: Buy
Price Target: €63.50 → €66.00
Current: €55.58
Upside: +18.75%
Novartis AG
Oct 28, 2026
Reiterated: Sell
Price Target: CHF 110.00 → CHF 113.00
Current: CHF 133.08
Upside: -15.09%
Roche Holding AG
Oct 23, 2026
Reiterated: Hold
Price Target: CHF 366.00 → CHF 391.00
Current: CHF 390.30
Upside: +0.18%
Sartorius Aktiengesellschaft
Oct 23, 2026
Reiterated: Hold
Price Target: €244.00 → €258.00
Current: €290.00
Upside: -11.03%
Sartorius Stedim Biotech S.A.
Oct 23, 2026
Reiterated: Buy
Price Target: €223.00 → €235.00
Current: €225.80
Upside: +4.07%
Lonza Group AG
Oct 1, 2026
Reiterated: Buy
Price Target: CHF 680.00
Current: CHF 663.40
Upside: +2.50%
Novo Nordisk
Aug 6, 2026
Reiterated: Hold
Price Target: $47 → $44
Current: $40.31
Upside: +9.15%
Sanofi
Jul 6, 2026
Reiterated: Hold
Price Target: €89.00 → €84.00
Current: €83.74
Upside: +0.31%
Merck KGaA
Apr 16, 2026
Reiterated: Buy
Price Target: €153.00 → €147.00
Current: €148.75
Upside: -1.18%
Roche Holding AG
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $59.37
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $162.55
Upside: n/a
Jul 30, 2025
Reiterated: Hold
Price Target: n/a
Current: $950.00
Upside: n/a
Jul 3, 2025
Reiterated: Hold
Price Target: $65 → $60
Current: $47.04
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: 13,930p
Upside: n/a
Oct 10, 2023
Reiterated: Hold
Price Target: €13.00 → €10.50
Current: €0.80
Upside: n/a
Sep 25, 2023
Reiterated: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: CHF 79.70
Upside: n/a
Sep 25, 2023
Reiterated: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: CHF 40.05
Upside: n/a
Sep 25, 2023
Reiterated: Buy
Price Target: €27.00 → €28.00
Current: €3.16
Upside: n/a
Sep 5, 2023
Reiterated: Hold
Price Target: €38.00 → €36.00
Current: €29.62
Upside: n/a
Aug 8, 2023
Reiterated: Buy
Price Target: $16 → $15
Current: $1.69
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $33.45
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $53.63
Upside: n/a